AzTrials
AzTrials

Blood Oxygen Saturation LevelNCT01732016

The Camera Oximeter: A Calibration Study

A study testing Normobaric hypoxia chamber in people with Blood Oxygen Saturation Level and Heart Rate, run by University of British Columbia at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pulse oximetry is a standard non-invasive method of measuring blood oxygen saturation (SpO2). In developing countries, pulse oximeters are rare because of expense and electricity requirements. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Blood Oxygen Saturation Level, Heart Rate
What is being tested?
Normobaric hypoxia chamber
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
Jan 2013to Aug 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Non-smokers
  • UBC students age 18 and older or non-university students age 19 and older
  • No medical history of respiratory, cardiovascular and neurological problems (capable of undergoing controlled hypoxemia down to SpO2 of 70%).

Who cannot join

  • Medical history including respiratory, cardiovascular and neurological problems
  • Smokers or individuals exposed to high levels of carbon monoxide that result in elevated carboxyhemoglobin levels (interferes with oximetry readings)

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • BC Children's Hospital

    Vancouver, British Columbia, V6H 3V4

Other trials in Canada

About this study

Pulse oximetry is a standard non-invasive method of measuring blood oxygen saturation (SpO2). In developing countries, pulse oximeters are rare because of expense and electricity requirements. Our ECEM group has developed the Phone Oximeter, which uses a cell phone (widely available in developing countries) to compute and analyze information from a pulse oximeter sensor. To further reduce costs, we use the integrated flashlight of a cell phone's camera to extract SpO2 (Camera Oximeter), eliminating the need for external hardware. This study aims to calibrate the Camera Oximeter by exposing 30 healthy adult volunteers to various altitudes in UBC's hypoxia chamber.

Read the detailed description

Purpose:

We at the Electrical and Computer Engineering in Medicine Group (ECEM) at the University of British Columbia, Vancouver, Canada, plan to make pulse oximetry available to resource poor countries by designing a low-cost, battery-powered pulse oximeter device. We have developed the Phone Oximeter, which uses a mobile phone to compute and analyze the information received from a pulse oximeter sensor. The use of mobile phones as patient monitors is appealing as they are widely available in many developing countries. Utilizing battery power, mobile phones do not rely on a continuous source of electricity. This is essential, as most low-resource settings lack adequate infrastructure and thus cannot provide the uninterrupted power supply required for conventional patient monitoring. Furthermore, a mobile phone has the efficiency, integrated display, and processing power required to analyze and store the data derived from the pulse oximeter sensors. Data from the pulse oximeter can be transmitted to referral centers for diagnostic and advisory purposes where cellular and networking services permit.

At present, the ECEM Phone Oximeter software runs on smartphones and receives input from an external proprietary oximeter sensor which is relatively expensive ($300 US). To further reduce cost and increase ubiquity of oximeters, we are developing two novel pulse oximeter systems for mobile phones that will be more integrated: the Audio Oximeter (AudioOx) and the Camera Oximeter. This study aims at calibrating the Camera Oximeter.

The Camera Oximeter uses the camera of a mobile phone as a photo detector. Illumination of the finger is provided through the integrated flash light. This allows completely eliminating external hardware, which allows the camera phone to become a standalone vital sign recording device at minimal cost (no additional cost other than the phone and the software). This principle has been applied in many mobile phone software applications available in various software repositories to measure the HR of the user. Preliminary research has shown that the extraction of SpO2 from a video recorded with a mobile phone is also possible. We have further extended this approach and want to calibrate and validate a software implementation of this approach.

Hypothesis:

We hypothesize that this study will allow us to successfully calibrate the Camera Oximeter.

Justification:

For the safety of the patient, the development of any new pulse oximeter equipment requires calibration and evaluation for accuracy. This is required to ensure that the pulse oximeter device is functional. Results of accuracy evaluations have to be reported so the clinician is informed and he/she can understand the limits of the device that he/she is using. The International Organization for Standardization (ISO) and a technical committee have created standards that regulate the calibration and accuracy evaluation procedures of pulse oximeters. These standards are enforced by regulatory bodies, such as the federal drug administration (FDA), to approve the medical device for its use.

Pulse Oximeter Theory and Calibration

The underlying principle of pulse oximeters is the Beer-Lambert law which stipulates that light intensity diminishes exponentially when traveling in an absorbing medium. Oxygenated (O2Hb) and de-oxygenated (Hb) hemoglobin have different extinction coefficients for different wavelengths and are the most important light absorbers in blood. In some wavelength ranges, Hb is more absorbent than O2Hb, and in others the absorption property is inverted. These regions are separated by isosbestic points. With each pulse, the volume of blood in the vessels and the optical path length increase, and therefore, the total absorbance also increases. As a result, the variation of volume can be registered as a variation of transmitted light intensity and recorded with a photodetector. This produces the PPG waveform. The difference in total absorbance at two distinct wavelengths allows the calculation of a modulation ratio R. The theoretical relationship between R and SaO2 can be described as:

SaO2 = (εHb(λ1) - εHb(λ2) x R) / (εHb(λ1) - εO2Hb(λ1) + (εO2Hb(λ2) - εHb(λ2)) x R)

The Beer-Lambert law ignores scattering of light. Various other design aspects of individual oximeters (e.g. photodetector quantum efficiency, probe type) are not taken into account in the theoretical equation. To account for these effects, the relationship between R and SaO2 has to be determined empirically using calibration.

The calibration of pulse oximeters for use on human subjects is regulated by ISO 80601-2-61. This standards document defines minimal requirements for devices, provides classification methods for systems, instructions how to measure accuracy of SpO2 and HR, and lists possible fault conditions. The standards document also provides informative recommendations on how to measure accuracy (Annex CC), standards for calibration (Annex DD), and guidelines for evaluating and documenting SpO2 accuracy in human subjects.

There is no standard tool for calibrating pulse oximeters. According to the ISO pulse oximetry standard document, "there is today no accepted method of verifying the correct calibration of a pulse oximeter probe/pulse oximeter monitor combination other than testing on human beings. This is due to the complexity of the optical intricacies of the interaction of light and human tissue upon which pulse oximetry depends". In-vitro calibration device prototypes using whole blood have been suggested in various research projects, but these systems are, to-date, not commercially available and very expensive to build and operate. They have not been accepted as standard tools for calibration because of their lack of simulating tissue interaction with pulse oximeter light. It is therefore necessary to calibrate pulse oximeters on human subjects.

For calibration and accuracy evaluation of SpO2 measurements, the ISO accepts two methods of testing:

Invasive testing: The SpO2 readings of the test pulse oximeter are compared to values of arterial blood oxygen saturations (SaO2) measured with a "gold standard" blood gas analysis using a CO-oximeter.

Non-invasive testing: The SpO2 readings of the test pulse oximeter are compared to values from a secondary standard pulse oximeter, which can be used as a transfer standard because its calibration is directly traceable to a blood gas analysis.

These tests can be conducted on healthy volunteers who consent to induced hypoxemia or patients from whom arterial blood samples/reference pulse oximeter readings are available.

Objectives:

Our main objective is to calibrate the Camera Oximeter. We will also evaluate the accuracy and reliability of the calibration to measure SpO2, respiratory rate, and heart rate measurements. Measurements produced by two secondary standard pulse oximeters and a capnometer (CO2 breath analyzer) will be used as reference monitors.

Research Method:

This will be a non-invasive testing on healthy subjects using two secondary standard, clinically approved pulse oximeters. The approved oximeters will provide the reference measurements for both SpO2 and HR. This is the least invasive approach that is recommended by the ISO standards.

Study subjects will be put into a hypoxic state by exposing them to normobaric (sea-level atmospheric pressure) hypoxia (low oxygen) by administrating an air mix containing a reduced O2 concentration. This is achieved in a hypoxia chamber where O2 concentration is gradually reduced to simulate high altitude (around 4500 m).

The goals of the current study are very similar to another study conducted in the hypoxia chamber (REB ID#H12-02365, Calibration and evaluation of an Audio Pulse Oximeter Sensor (AudioOx) at ascent and descent from simulated altitude), the same methodology is applied. This will allow recruiting subjects for both studies and will reduce the total number of subjects necessary for achieving our goal.

Statistical Analysis:

Calibration of SpO2 Data from the initial set of subjects (at least 10) in the study will be used to calibrate the Camera Oximeter oximetry data. Firstly, the red and infra-red (IR) light signals from oximeter sensors are used to calculate ratio R, where

R = ( ACRED / DCRED ) / ( ACIR / DCIR )

ACRED and ACIR are pulsatile components of the red and infra-red light detected by the oximeter photo detector. DCRED and DCIR are constant components of the red and infra-red light detected by the oximeter photo detector.

R values are paired to SpO2 readings from the reference oximeter taken at the same time. Linear regression on a second order polynomial equation is then used to estimate the calibration parameters.

Evaluation of SpO2 Readings from later subjects (at least 10) will be used to evaluate the accuracy and validity of the SpO2 measurements from both novel oximeters. Paired readings from the test oximeters and the reference oximeter are grouped into six ranges (70-75%, 76-80%, 81-85%, 86-90%, 91-95% and 96-100%). Mean bias, precision and accuracy will be calculated as per ISO definitions for each group of SpO2 ranges and the overall range (70-100%) [5].

Local bias, b, is the difference between the expectation of the test results (SpO2) and an accepted reference value (SR). For pulse oximetry, this is, at a given value of the reference SpO2, the difference between the y-value of the regression line at that coordinate and the y-value of the line of identity, in a plot of SpO2 versus SR, or given by:

Local bias, bi = SpO2 fit,i - SRi

where SpO2 fit,i is the value of the curve fitted to the test data at the ith reference SpO2 value, SRi.

Mean bias, B, is mean difference between the test and reference values, preserving sign (average of all local bias values):

Mean bias, B = (∑i=1 to n (bi))/n

Precision is the closeness of agreement between independent test results obtained under stipulated conditions, defined as the standard deviation of the residuals (Sres), given by:

Precision, Sres = √(∑i=1 to n (SpO2i - SpO2fit,i)^2 )/(n-2))

where n is the number of data pairs in the sample within the range of interest; (SpO2,i - SpO2 fit,i) is the difference between the ith SpO2 datum and the value of the fitted curve corresponding to the ith reference SpO2 value, SRi.

Accuracy of the pulse oximeter shall be stated in terms of the root-mean-square (rms) difference between measured values (SpO2,i) and reference values (SRi), as given by:

Accuracy = √((∑i=1 to n(SpO2i- SRi)^2 )/n)

To express ACCURACY relative to the "gold-standard" blood gas analysis, the error of the secondary standard pulse oximeter (errorref) has to be included, thereby:

Accuracycorrected = √Arms^2 + error(ref)^2

Evaluation of HR Readings from later subjects (at least 10) will be used to evaluate the accuracy and validity of HR measurements from the novel oximeter. Paired HR readings from the test oximeter and the reference oximeters are grouped into four ranges (40-65, 66-90, 91-115, and 116-140 beats per minute (bpm)). Mean bias, precision and accuracy are calculated as per ISO definitions for each group of HR ranges and the overall range (40-140 bpm), as detailed previously for SpO2.

Evaluation of Respiratory Rate Readings from later subjects (at least 10) will be used to evaluate the accuracy and validity of respiratory rate measurements extracted from the plethysmogram that was recorded with the Camera Oximeter. Paired respiratory rate readings from the test oximeter and the reference capnometry are grouped into three ranges (0-8, 9-16, and >17 breaths per minute). Mean bias, precision and accuracy are calculated for each group of respiratory range and the overall range.

Being tested
Normobaric hypoxia chamber
Keywords
pulse oximeter, oxygen saturation, heart rate, calibration, accuracy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Normobaric hypoxia chamberOther

Study groups in NCT01732016
Study groupRoleWhat they receive
Normobaric hypoxia chamberOtherStudy subjects will be put into a hypoxic state by exposing them to normobaric (sea-level atmospheric pressure) hypoxia (low oxygen) by administrating an air mix containing a reduced O2 concentration. This is achieved in a hypoxia chamber where O2 concentration is gradually reduced to simulate high altitude (around 4500 m).
Receives: Other: Normobaric hypoxia chamber

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygen saturation

    Accurately calibrated Camera Oximeter for measuring oxygen saturation.

    Measured: Across 3 hours

Secondary outcomes (2)
  1. Heart rate

    Accurately calibrated Camera Oximeter for measuring heart rate.

    Measured: Across 3 hours

  2. Respiratory rate

    Accurately calibrated Camera Oximeter for measuring respiratory rate.

    Measured: Across 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2012 (estimated)
  2. Study startJan 2013
  3. Primary completionAug 2013
  4. Study completionAug 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01732016
Sponsor's protocol ID
H12-02362
Status last verified
Jun 2017
First submitted
16 Nov 2012
Last updated
26 Jun 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Normobaric hypoxia chamber in people with Blood Oxygen Saturation Level and Heart Rate, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygen saturation (time frame: Across 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in